by Leanne Talbot | Feb 4, 2019
This World Cancer Day we’re asking you to make your voice count for the Neuroendocrine Cancer community by joining our new Faces of NETs campaign. Over 40,000 people are affected by Neuroendocrine Cancer (NETs) in the UK, with over 5,000 people newly... by Leanne Talbot | Jan 31, 2019
We’re delighted to share with you our first edition of NET News Magazine. As you read through this magazine, you will see that there are multiple components to running a patient organisation. We are a ‘small but vital charity’ doing a wide range of activities,... by Leanne Talbot | Jan 28, 2019
NET Patient Foundation in association with The Christie Hospital’s NET team held a dedicated NET Patient Education Meeting on Friday 25th January. There was an amazing turn out by NET patients, supporters and the NET team from The Christie Hospital. Linda... by Leanne Talbot | Jan 28, 2019
On Friday 18th January, NPF’s Chief Executive, Catherine Bouvier, and AMEND’S CEO, Jo Grey, met the ACC Research Team led by Wiebke Arlt at Birmingham University. There is a huge enthusiasm and drive to improve the pathway for Adrenocorticol... by Leanne Talbot | Jan 28, 2019
NPF’s Chief Executive, Catherine Bouvier, attended the Cancer52 All Member Meeting on 23rd January. An interesting meeting with presentations from the Association of the the British Pharmaceutical Industry (ABPI) and the National Cancer Programme Director... by Leanne Talbot | Jan 28, 2019
NET Patient Foundation, alongside other members of the NET community were bought together for a one day workshop to share our experiences of the disease and our opinions about how ONO Pharmaceuticals can contribute to the unmet needs of NET patients. They have a NET... 